ENDPOINTS

Novo Nordisk signs $354M partnership with AI-guided biotech for ‘risky’ new metabolic mechanisms

Novo Nordisk has formed a $354 million research collaboration with Gensaic, the protein design company said on Monday, as the Danish pharma giant works to incubate new approaches in the metabolic ...

Mar 3, 2025 - 15:22
 0
Novo Nordisk signs $354M partnership with AI-guided biotech for ‘risky’ new metabolic mechanisms
Novo Nordisk has formed a $354 million research collaboration with Gensaic, the protein design company said on Monday, as the Danish pharma giant works to incubate new approaches in the metabolic ...
Read More

Tags:

Previous Article

You should add keyboard shortcuts to your Mac

Next Article

Online Dating Company Announces $20M Annual Fund to Accelerate “virtual intimacy...

Related Posts

Pfizer ends rollout of Beqvez, putting another dent in hemophilia gene therapy field

Pfizer ends rollout of Beqvez, putting another dent in ...

Feb 21, 2025  0

AbbVie finally enters obesity race with $350M upfront for Gubra’s amylin

AbbVie finally enters obesity race with $350M upfront f...

Mar 3, 2025  0

ICER finds GSK inhalers offer advantages over generics

ICER finds GSK inhalers offer advantages over generics

Mar 3, 2025  0